• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    B. Riley Securities initiated coverage on GT Biopharma with a new price target

    4/13/21 6:45:30 AM ET
    $GTBP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GTBP alert in real time by email
    B. Riley Securities initiated coverage of GT Biopharma with a rating of Buy and set a new price target of $21.00
    Get the next $GTBP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GTBP

    DatePrice TargetRatingAnalyst
    12/2/2024$11.00Buy
    ROTH MKM
    More analyst ratings

    $GTBP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on GT Biopharma with a new price target

      ROTH MKM initiated coverage of GT Biopharma with a rating of Buy and set a new price target of $11.00

      12/2/24 10:00:20 AM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. initiated coverage on GT Biopharma with a new price target

      HC Wainwright & Co. initiated coverage of GT Biopharma with a rating of Buy and set a new price target of $25.00

      5/24/21 6:11:36 AM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • B. Riley Securities initiated coverage on GT Biopharma with a new price target

      B. Riley Securities initiated coverage of GT Biopharma with a rating of Buy and set a new price target of $21.00

      4/13/21 6:45:30 AM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GTBP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Kramer Hilary

      3 - GT Biopharma, Inc. (0000109657) (Issuer)

      6/3/25 4:15:22 PM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by new insider Ritter Andrew J

      3 - GT Biopharma, Inc. (0000109657) (Issuer)

      5/29/25 4:15:10 PM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Urban Alan Louis

      4 - GT Biopharma, Inc. (0000109657) (Issuer)

      10/21/24 9:13:40 PM ET
      $GTBP
      Biotechnology: Pharmaceutical Preparations
      Health Care